| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/11/2005 | CN1615368A Effectors of innate immunity |
| 05/11/2005 | CN1615364A HIV-1 virus tat-protein mutants |
| 05/11/2005 | CN1615301A Dithiocarbamate derivatives and their use as antibacterial agents |
| 05/11/2005 | CN1615141A Use of polysaccharide derivatives as anti-infective substances |
| 05/11/2005 | CN1614030A Gene artificial synthesis and SARS virus protective antigen-amino acid series |
| 05/11/2005 | CN1614028A Dried bacterial powder process containing gamma-linolenic acid |
| 05/11/2005 | CN1614011A Technology for closed double-circulating column chromatographing purifying inactivated virus vaccine |
| 05/11/2005 | CN1613874A Human tumour necrosin antibody, its preparation and medicinal composition |
| 05/11/2005 | CN1613872A Interferon of IFN-beta-cn and its mutant |
| 05/11/2005 | CN1613870A Tetramer combined with SARS antigen peptide and its preparation and use |
| 05/11/2005 | CN1613858A Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations |
| 05/11/2005 | CN1613853A PDF enzyme inhibitor-hydroxamic acid serial compounds synthetic method and use thereof |
| 05/11/2005 | CN1613500A AIDS virus oral liquid |
| 05/11/2005 | CN1613494A External used medicine for inhibiting fungus |
| 05/11/2005 | CN1613491A Decoction for treating tuberculosis |
| 05/11/2005 | CN1613486A Composite cottonrose hibiscus and mongolia bark drop pellets and their preparation |
| 05/11/2005 | CN1613484A Compound Astragalus mongholicus drop pellets and preparation |
| 05/11/2005 | CN1613483A Cold preventing medicine |
| 05/11/2005 | CN1613475A Chinese medicine for treating liver diseases |
| 05/11/2005 | CN1613474A Antitubercular Chinese medicine |
| 05/11/2005 | CN1613473A Preparation of anti-bacteria powders for poultry |
| 05/11/2005 | CN1613465A Oral liquid for hlepatitis B |
| 05/11/2005 | CN1613456A Freezing dried mycobatctericsis preparation and its preparing method and use |
| 05/11/2005 | CN1613453A Azithromycin injection and its preparation |
| 05/11/2005 | CN1613451A Powder injection of lactatelevo-ofloxacin and its preparation |
| 05/11/2005 | CN1613446A Sustained released malotilate preparation for hepa titis and cirrhosis |
| 05/11/2005 | CN1200951C Process for productio nof multiple cross-linked hyaluronic acid derivatives |
| 05/11/2005 | CN1200941C Intermediates in cephalosporing production, intermediate and its use therein |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/11/2005 | CN1200938C Process for preparing 8-methoxy-quinolone |
| 05/11/2005 | CN1200733C Reversal of viral-induced systemic shock and respiratory distress by blockade of lymphotoxin beta pathway |
| 05/11/2005 | CN1200731C Derivatives of pneumococcal choline binding proteins for vaccines |
| 05/11/2005 | CN1200730C Pneumococcal and Meningococcal vaccines formulated with interleukin-12 |
| 05/11/2005 | CN1200723C White peony and licorice extract and its prepn process |
| 05/11/2005 | CN1200715C Adetphos sodium chloride injection and its preparation method |
| 05/11/2005 | CN1200708C Application of tetracyclic coumarin compounds in preparing anti-HIV medicine |
| 05/11/2005 | CN1200705C Use of dicaffeoylquinic acid derivative and analogs in treating disease related to coronavirus infection |
| 05/11/2005 | CN1200684C Compositions comprising organosiloxane resins for delivering oral care substances |
| 05/11/2005 | CN1200673C Antimicotic nail varnish composition |
| 05/10/2005 | US6890949 Amino ceramide-like compounds and therapeutic methods of use |
| 05/10/2005 | US6890938 Antiinflammatory agents |
| 05/10/2005 | US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/10/2005 | US6890927 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 05/10/2005 | US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 05/10/2005 | US6890911 Method for the treatment of inflammation |
| 05/10/2005 | US6890908 Modified ribozymes |
| 05/10/2005 | US6890907 Method of treating endobronchial infection by administering a nebulized unit dosage of an aqueous solution of tobramycin over given dosage and time, as well as specified aerosol particle sizes |
| 05/10/2005 | US6890902 Cytotoxic modified lactoferrin peptides |
| 05/10/2005 | US6890900 Methods for treating or preventing diseases of the oral cavity |
| 05/10/2005 | US6890710 For treating influenza infections in vivo; fusion proteins; solid phase synthesis |
| 05/10/2005 | US6890547 Glycyrrhizin preparations for transmucosal absorption |
| 05/10/2005 | US6890546 Stents, catheters, arterio-venous grafts, by-pass grafts and drug delivery ballons with surface coating containing a rapamycin derivative having a tetrazole group |
| 05/10/2005 | US6890545 Fungicide and method for producing the same |
| 05/10/2005 | US6890540 Vaccine formulation |
| 05/10/2005 | US6890538 Immunization against herpes simplex virus |
| 05/10/2005 | US6890532 Postexposure prophylaxis therapy |
| 05/10/2005 | US6890527 Methods of treatment |
| 05/10/2005 | US6890523 Administering a polymer with pendant acid functional groups or a salt with a pharmaceutically acceptable cation; free of acid anhydride groups; antidiarreah agents |
| 05/10/2005 | CA2378862C Multi-component vaccine to protect against disease caused by haemophilus influenzae and moraxella catarrhalis |
| 05/10/2005 | CA2330935C A mutant human hepatitis b viral strain and uses thereof |
| 05/10/2005 | CA2123579C Recombinant multivalent m protein vaccine |
| 05/10/2005 | CA2097044C Cyclopentane- and -pentene-.beta.-amino acids |
| 05/10/2005 | CA2067330C Herpes simplex virus type 1 mutant |
| 05/10/2005 | CA1341482C Process for preparing fragments of aids-associated retroviruses |
| 05/07/2005 | CA2460384A1 Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations |
| 05/06/2005 | WO2005040221A1 Correlation between the fucose content / galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activity |
| 05/06/2005 | WO2005039602A1 Pharmacologically functional water and use thereof |
| 05/06/2005 | WO2005039599A1 Matrix metalloprotease inhibitor containing polylactic acid mixture |
| 05/06/2005 | WO2005021031A3 Live attenuated bacterial vaccine |
| 05/06/2005 | WO2005009448A8 Treatment of lesions of the soft tissues |
| 05/06/2005 | WO2005009368A3 Antibiotic product, use and formulation thereof |
| 05/06/2005 | WO2004096194A3 Prevention of hiv-1 infection by inhibition of rho-mediated reorganization and/or content alteration of cell membrane raft domains |
| 05/06/2005 | WO2004044220A3 Flaviviris fusion inhibitors |
| 05/06/2005 | WO2004043928A8 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents |
| 05/06/2005 | WO2003068146A3 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/06/2005 | WO2003062394A3 Methods and compositions for rna interference |
| 05/06/2005 | WO2003018606A3 Casein derived peptides and uses thereof in therapy |
| 05/06/2005 | WO2003010286A3 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 05/06/2005 | WO2002095007A3 Conjugates activated by cell surface proteases and therapeutic uses thereof |
| 05/06/2005 | CA2543318A1 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |
| 05/06/2005 | CA2542967A1 Inosine monophosphate dehydrogenase inhibitors as phosphonate derivatives |
| 05/06/2005 | CA2542881A1 Antibody with an optimized fucose content/galactose content ratio |
| 05/06/2005 | CA2542175A1 Vaccines containing the hiv tat protein as an adjuvant for the enhancement of cytotoxic t-cell responses |
| 05/06/2005 | CA2541695A1 Vaccine compositions comprising an interleukin 18 and saponin adjuvant system |
| 05/06/2005 | CA2541497A1 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site |
| 05/06/2005 | CA2539726A1 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| 05/06/2005 | CA2537224A1 Heterocycle-substituted pteridine derivatives and their use in therapy |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096446 Tri-block copolymers and a process for the preparation of the same |
| 05/05/2005 | US20050096388 Compositions and methods for treating or preventing diseases of body passageways |
| 05/05/2005 | US20050096359 melanocortin receptor agonist, antagonist; preventing or treating inflammatory diseases, AIDS, obesity, bulimia, anorexia or sexual dysfunction; N-(2-aminoethyl)-3'-[1-{N-(1-benzylpiperidin-4-yl)-N-(2-naphthylacetyl)aminoethyl][1,1'-biphenyl)-2-carboxamide dihydrochloride |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050096343 pharmocophores of quinolone and oxazolidinone chemicaly linked; against a variety of multi-drag resistant bacteria; staphylococci, enterococci, Moraxella catarrhalis, haemophilus influenza, bacteroides, Clostridia, Mycobacterium tuberculosis, Mycobacterium avium |
| 05/05/2005 | US20050096335 Heteroaryl - fused nitrogen heterocycles as therapeutic agents |
| 05/05/2005 | US20050096313 Substance P; 2-(phenyl)-4-(3-oxo-piperazin-1-yl-)-piperidine-1-carboxylic acid; benzyl-methylamide; antagonists of the NK1 receptor; antidepressant, antiolytic; antiemetic |
| 05/05/2005 | US20050096308 Antibacterial agents |
| 05/05/2005 | US20050096297 Antibacterial agents |
| 05/05/2005 | US20050096278 Antibacterial agents |
| 05/05/2005 | US20050096229 Biocidal compounds and their preparation |
| 05/05/2005 | US20050095686 Preparing starch composition to improve structure, texture and stability of food; for use in prevention and treatment of infection, immunological and tumor disorders |